Background: venoms of a variety of animal species (ie scorpions, snakes, spiders, sea
anemones, marine cone snails, worms, and insects) are rich sources of bioactive …

Animal venoms are rich sources of bioactive compounds that possess obvious
pharmacological, therapeutic, and/or bio technological values. A majority of these …

To the general public, venomous animals often evoke repulsion or even uncontrollable fear,
yet they also fascinate by their almost mystical dimension. For researchers, however, they …

Biodiversity provides a huge source of new chemical entities that could be useful for the
development of new therapies. An example is venomous animals, which produce venoms …

Snake and spider venoms have been developed by nature as a defense mechanism against
predators or to immobilize their prey by blocking the cardiovascular, respiratory, and/or …

Venoms from marine and terrestrial animals (cone snails, scorpions, spiders, snakes,
centipedes, cnidarian, etc.) can be seen as an untapped cocktail of biologically active …

International Journal of Peptide Research and Therapeutics technologies, functional genetic
information can be determined (Banshidhar et al. 2023). This information is translated in the …

Introduction: An extraordinarily diverse range of animals have evolved venoms for predation,
defence, or competitor deterrence. The major components of most venoms are peptides and …

Highlights•More than ten toxin derived peptides have entered clinical study for pain.•Major
targets for pain therapeutics include Na V s, Ca V s, and ASICs.•Selectivity and target …